Cargando…
Niclosamide ethanolamine improves blood glycemic control and reduces hepatic steatosis in mice
Type 2 diabetes (T2D) has reached an epidemic level globally. Most current treatments ameliorate the hyperglycemic symptom but are not effective in correcting the underlying cause. One important causal factor of T2D is ectopic accumulation of lipid in organs such as liver and muscle. Mitochondrial u...
Autores principales: | Tao, Hanlin, Zhang, Yong, Zeng, Xiangang, Shulman, Gerald I., Jin, Shengkan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4299950/ https://www.ncbi.nlm.nih.gov/pubmed/25282357 http://dx.doi.org/10.1038/nm.3699 |
Ejemplares similares
-
Effect of mitochondrial uncouplers niclosamide ethanolamine (NEN) and oxyclozanide on hepatic metastasis of colon cancer
por: Alasadi, Amer, et al.
Publicado: (2018) -
Niclosamide ethanolamine ameliorates diabetes-related muscle wasting by inhibiting autophagy
por: Cai, Yuchun, et al.
Publicado: (2021) -
Single-dose pharmacokinetics and lung function of nebulized niclosamide ethanolamine in sheep
por: Weiss, Anne, et al.
Publicado: (2023) -
Combined treatment with niclosamide ethanolamine and artemether combination improves type 1 diabetes via the targeting of liver mitochondria
por: Weng, Wenci, et al.
Publicado: (2022) -
Niclosamide Ethanolamine Salt Alleviates Idiopathic Pulmonary Fibrosis by Modulating the PI3K-mTORC1 Pathway
por: Pei, Xiaolin, et al.
Publicado: (2022)